Skip to main content
Caplight Logo









Intelliseq

Intelliseq

Private
PolandHealthcare & Life Scienceshttps://intelliseq.com/

Last Round

Series A

Mar 28, 2025

Total Funding Raised

$6.46M

Company Overview

Intelliseq is a biotechnology company that develops and provides a bioinformatics platform for automated analysis and interpretation of the human genome.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

bioinformaticsnext-generation sequencingNGSgenomic data analysisclinical decision supportvariant interpretationprecision medicinegenomic reportingpharmacogenomicsPGxpolygenic risk scorePRSgenomic softwareclinical genomicsgenomics aibioinformatics pipelinegenomic interpretationgenomics as a service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Intelliseq Comparables

Compare Intelliseq with similar companies based on industry and business-model similarity.

Intelliseq comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SeqOne
86%
Saphetor
84%
Limbus Medical Technologies GmbH
84%

Intelliseq Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 28, 2025
SeedNov 7, 2022

Key People

Founding team and executive leadership

Marcin Piechota

Chief Technology Officer & Co-founder

Founding Team

Slawomir Golda

Co-founder And Chief Operations Officer

Founding Team

Klaudia Szklarczyk-Smolana

CEO, Co-founder

Founding Team

Intelliseq Investors

Notable investors and investment history

Intelliseq investors
InvestorRounds
Unfold.vcSeries A, Seed
Vinci S.A.Series A
YouNick MintSeed
Vinci HiTech ASISeries A
COBIN AngelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors grew 243% MoM, reaching 2K.

  • Dec 20, 2025

    Added Telostrand Laboratory, LLC. in Biotechnology/Life Sciences.

Intelliseq Filings

Explore SEC and related filing metadata, where available.

Intelliseq filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Intelliseq's valuation, stock price, and market status.

Is Intelliseq a public or private company?

Intelliseq is a private company.

What is the current stock price of Intelliseq?

Intelliseq is a private company with no public stock price. No recent secondary market data is available.

How much is Intelliseq worth (valuation)?

Valuation information for Intelliseq is not publicly available.

Can I buy Intelliseq stock?

Intelliseq shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Intelliseq's last funding round?

Intelliseq's most recent funding round was Series A on March 28, 2025.

Who are the main investors in Intelliseq?

Key investors in Intelliseq include YouNick Mint.

Will Intelliseq IPO soon?

No public IPO plans have been announced for Intelliseq.

How can I track Intelliseq secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Intelliseq's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPoland
Employee Range13
Year Founded2014
Last FundingMar 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?